BBCMF (Lir Life Sciences) Gross Profit: $0.00 Mil (TTM As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Gross Profit?

Lir Life Sciences BBCMF 15 Gross Profit is $0.00 Mil as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Lir Life Sciences's gross profit for the three months ended in Jan. 2026 was $0.00 Mil. Lir Life Sciences's gross profit for the trailing twelve months (TTM) ended in Jan. 2026 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Lir Life Sciences's gross profit for the three months ended in Jan. 2026 was $0.00 Mil. Lir Life Sciences's Revenue for the three months ended in Jan. 2026 was $0.00 Mil. Therefore, Lir Life Sciences's Gross Margin % for the quarter that ended in Jan. 2026 was N/A%.

Lir Life Sciences had a gross margin of N/A% for the quarter that ended in Jan. 2026 => No sustainable competitive advantage

Lir Life Sciences  (OTCPK:BBCMF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Lir Life Sciences had a gross margin of N/A% for the quarter that ended in Jan. 2026 => No sustainable competitive advantage

Lir Life Sciences Gross Profit Related Terms

Lir Life Sciences Gross Profit Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Gross Profit Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Gross Profit
0.00 0.00

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Gross Profit Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

BBCMF vs VRTX, REGN, ALNY: Gross Profit Comparison

For the Biotechnology subindustry, Lir Life Sciences's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lir Life Sciences Gross Profit vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lir Life Sciences's Gross Profit distribution charts can be found below:

* The bar in red indicates where Lir Life Sciences's Gross Profit falls into.


BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Gross Profit is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Lir Life Sciences's Gross Profit for the fiscal year that ended in Apr. 2025 is calculated as

Gross Profit (A: Apr. 2025 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Lir Life Sciences's Gross Profit for the quarter that ended in Jan. 2026 is calculated as

Gross Profit (Q: Jan. 2026 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Lir Life Sciences's Gross Margin % for the quarter that ended in Jan. 2026 is calculated as

Gross Margin % (Q: Jan. 2026 )=Gross Profit (Q: Jan. 2026 ) / Revenue (Q: Jan. 2026 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Profit →
What does a Gross Profit of $0.00 Mil mean?
Lir Life Sciences (BBCMF) has a Gross Profit of $0.00 Mil as of Jan. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Lir Life Sciences and its competitors.
Is Lir Life Sciences' Gross Profit too high?
Lir Life Sciences' current Gross Profit is $0.00 Mil. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Gross Profit compare to VRTX and REGN?
Lir Life Sciences' Gross Profit of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Biotechnology company?
A good Gross Profit depends on the Biotechnology industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Lir Life Sciences and its competitors. Lir Life Sciences's current Gross Profit is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Gross Profit of $0.00 Mil. The current Gross Profit is $0.00 Mil. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Gross Profit is $0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price